151751-Najiba-Chargi

378 CHAPTER 18 14. Nishikawa D, Hanai N, Suzuki H, Koide Y, Beppu S, Hasegawa Y. The Impact of Skel - etal Muscle Depletion on Head and Neck Squamous Cell Carcinoma. ORL J Oto- rhinolaryngol Relat Spec . 2018;80(1):1-9. doi:10.1159/000485515 15. Miyamoto Y, Baba Y, Sakamoto Y, et al. Sar - copenia is a Negative Prognostic Factor After Curative Resection of Colorectal Cancer. Ann Surg Oncol . 2015;22(8):2663- 2668. doi:10.1245/s10434-014-4281-6 16. Okumura S, Kaido T, Hamaguchi Y, et al. Impact of preoperative quality as well as quantity of skeletal muscle on survival after resection of pancreatic cancer. Sur- gery . 2015;157(6):1088-1098. doi:10.1016/j. surg.2015.02.002 17. Tanaka M, Okada H, Hashimoto Y, Kumagai M, Nishimura H, Fukui M. Low-attenuation muscle is a predictor of diabetes mellitus: A population-based cohort study. Nutrition . 2020;74. doi:10.1016/j.nut.2020.110752 18. B. Heymsfield S, Wang Z, Baumgartner RN, Ross R. Human Body Composition: Advanc - es in Models and Methods. Annu Rev Nutr . 1997;17(1):527-558. doi:10.1146/annurev. nutr.17.1.527 19. Swartz JE, Pothen AJ, Wegner I, et al. Feasibility of using head and neck CT im - aging to assess skeletal muscle mass in head and neck cancer patients. Oral Oncol . 2016;62:28-33. doi:10.1016/j.oraloncolo - gy.2016.09.006 20. Studenski S, Perera S, Wallace D, et al. Phys - ical performance measures in the clinical setting. J Am Geriatr Soc . 2003;51(3):314- 322. doi:10.1046/j.1532-5415.2003.51104.x 21. Morishita S. Prevalence of Sarcopenia in Cancer Patients: Review and Future Direc - tions. Int J Phys Med Rehabil . 2016;04(03). doi:10.4172/2329-9096.1000342 22. Hairi NN, Cumming RG, Naganathan V, et al. Loss of muscle strength, mass (sarco - penia), and quality (specific force) and its relationship with functional limitation and physical disability: The concord health and ageing in men project. J Am Geriatr Soc . 2010;58(11):2055-2062. doi:10.1111/j.1532- 5415.2010.03145.x 23. Zoico E, Di Francesco V, Guralnik JM, et al. Physical disability and muscular strength in relation to obesity and different body composition indexes in a sample of healthy elderly women. Int J Obes . 2004;28(2):234- 241. doi:10.1038/sj.ijo.0802552 24. Grotenhuis BA, Shapiro J, van Adrichem S, et al. Sarcopenia/Muscle Mass is not a Prognostic Factor for Short- and Long- Term Outcome After Esophagectomy for Cancer. World J Surg . 2016;40(11):2698- 2704. doi:10.1007/s00268-016-3603-1 25. Awad S, Tan BH, Cui H, et al. Marked chang - es in body composition following neo- adjuvant chemotherapy for oesophago- gastric cancer. Clin Nutr . 2012;31(1):74-77. doi:10.1016/j.clnu.2011.08.008 26. Yip C, Goh V, Davies A, et al. Assessment of sarcopenia and changes in body com- position after neoadjuvant chemother - apy and associations with clinical out- comes in oesophageal cancer. Eur Radiol . 2014;24(5):998-1005. doi:10.1007/s00330- 014-3110-4 27. Sheetz KH, Zhao L, Holcombe SA, et al. Decreased core muscle size is associat- ed with worse patient survival following esophagectomy for cancer. Dis Esophagus . 2013;26(7):716-722. doi:10.1111/dote.12020 28. Zhang S, Tan S, Jiang Y, et al. Sarcopenia as a predictor of poor surgical and oncologic outcomes after abdominal surgery for di - gestive tract cancer: A prospective cohort study. Clin Nutr . 2019;38(6):2881-2888. doi:10.1016/j.clnu.2018.12.025